-
Something wrong with this record ?
Autoradiographic imaging and quantification of the high-affinity GHB binding sites in rodent brain using3H-HOCPCA
AB. Klein, T. Bay, IS. Villumsen, CB. Falk-Petersen, A. Marek, B. Frølund, RP. Clausen, HD. Hansen, GM. Knudsen, P. Wellendorph,
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Autoradiography methods MeSH
- Cyclopentanes pharmacology MeSH
- Rodentia MeSH
- Hydroxybutyrates pharmacology MeSH
- Binding, Competitive MeSH
- Carboxylic Acids pharmacology MeSH
- Brain drug effects metabolism MeSH
- Mice MeSH
- Radioligand Assay methods MeSH
- Binding Sites MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
GHB (γ-hydroxybutyric acid) is a compound endogenous to mammalian brain with high structural resemblance to GABA. GHB possesses nanomolar-micromolar affinity for a unique population of binding sites, but the exact nature of these remains elusive. In this study we utilized the highly selective GHB analogue, 3-hydroxycyclopent-1-enecarboxylic acid (HOCPCA) as a tritiated version (3H-HOCPCA) to radioactively label the specific GHB high-affinity binding site and gain further insight into the density, distribution and developmental profile of this protein. We show that, in low nanomolar concentrations,3H-HOCPCA displays excellent signal-to-noise ratios using rodent brain autoradiography, which makes it a valuable ligand for anatomical quantification of native GHB binding site levels. Our data confirmed that3H-HOCPCA labels only the high-affinity specific GHB binding site, found in high density in cortical and hippocampal regions. The experiments revealed markedly stronger binding at pH 6.0 (Kd73.8 nM) compared to pH 7.4 (Kd2312 nM), as previously reported for other GHB radioligands but similar Bmaxvalues. Using3H-HOCPCA we analyzed the GHB binding protein profile during mouse brain development. Due to the high sensitivity of this radioligand, we were able to detect low levels of specific binding already at E15 in mouse brain, which increased progressively until adulthood. Collectively, we show that3H-HOCPCA is a highly sensitive radioligand, offering advantages over the commonly used radioligand3H-NCS-382, and thus a very suitable in vitro tool for qualitative and quantitative autoradiography of the GHB high-affinity site.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18011027
- 003
- CZ-PrNML
- 005
- 20180420094116.0
- 007
- ta
- 008
- 180404s2016 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.neuint.2016.09.002 $2 doi
- 035 __
- $a (PubMed)27615059
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Klein, A B $u Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.
- 245 10
- $a Autoradiographic imaging and quantification of the high-affinity GHB binding sites in rodent brain using3H-HOCPCA / $c AB. Klein, T. Bay, IS. Villumsen, CB. Falk-Petersen, A. Marek, B. Frølund, RP. Clausen, HD. Hansen, GM. Knudsen, P. Wellendorph,
- 520 9_
- $a GHB (γ-hydroxybutyric acid) is a compound endogenous to mammalian brain with high structural resemblance to GABA. GHB possesses nanomolar-micromolar affinity for a unique population of binding sites, but the exact nature of these remains elusive. In this study we utilized the highly selective GHB analogue, 3-hydroxycyclopent-1-enecarboxylic acid (HOCPCA) as a tritiated version (3H-HOCPCA) to radioactively label the specific GHB high-affinity binding site and gain further insight into the density, distribution and developmental profile of this protein. We show that, in low nanomolar concentrations,3H-HOCPCA displays excellent signal-to-noise ratios using rodent brain autoradiography, which makes it a valuable ligand for anatomical quantification of native GHB binding site levels. Our data confirmed that3H-HOCPCA labels only the high-affinity specific GHB binding site, found in high density in cortical and hippocampal regions. The experiments revealed markedly stronger binding at pH 6.0 (Kd73.8 nM) compared to pH 7.4 (Kd2312 nM), as previously reported for other GHB radioligands but similar Bmaxvalues. Using3H-HOCPCA we analyzed the GHB binding protein profile during mouse brain development. Due to the high sensitivity of this radioligand, we were able to detect low levels of specific binding already at E15 in mouse brain, which increased progressively until adulthood. Collectively, we show that3H-HOCPCA is a highly sensitive radioligand, offering advantages over the commonly used radioligand3H-NCS-382, and thus a very suitable in vitro tool for qualitative and quantitative autoradiography of the GHB high-affinity site.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a autoradiografie $x metody $7 D001345
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a kompetitivní vazba $7 D001667
- 650 _2
- $a mozek $x účinky léků $x metabolismus $7 D001921
- 650 _2
- $a kyseliny karboxylové $x farmakologie $7 D002264
- 650 _2
- $a cyklopentany $x farmakologie $7 D003517
- 650 _2
- $a hydroxybutyráty $x farmakologie $7 D006885
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a radioligandová zkouška $x metody $7 D011869
- 650 _2
- $a hlodavci $7 D012377
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bay, T $u Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.
- 700 1_
- $a Villumsen, I S $u Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.
- 700 1_
- $a Falk-Petersen, C B $u Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.
- 700 1_
- $a Marek, A $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 16610 6 Prague, Czech Republic.
- 700 1_
- $a Frølund, B $u Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.
- 700 1_
- $a Clausen, R P $u Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.
- 700 1_
- $a Hansen, H D $u Neurobiology Research Unit and Center for Integrated Molecular Brain Imaging, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
- 700 1_
- $a Knudsen, G M $u Neurobiology Research Unit and Center for Integrated Molecular Brain Imaging, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
- 700 1_
- $a Wellendorph, P $u Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark. Electronic address: pw@sund.ku.dk.
- 773 0_
- $w MED00003485 $t Neurochemistry international $x 1872-9754 $g Roč. 100, č. - (2016), s. 138-145
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27615059 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180420094218 $b ABA008
- 999 __
- $a ok $b bmc $g 1288512 $s 1007839
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 100 $c - $d 138-145 $e 20160908 $i 1872-9754 $m Neurochemistry international $n Neurochem Int $x MED00003485
- LZP __
- $a Pubmed-20180404